EMERALD MUTUAL FUND ADVISERS TRUST - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 79 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
EMERALD MUTUAL FUND ADVISERS TRUST ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$1,268,000
-20.4%
307,723
-50.5%
0.06%
-25.3%
Q2 2020$1,592,000
-7.7%
622,049
+4.2%
0.08%
-30.6%
Q1 2020$1,725,000
-18.3%
597,049
+7.2%
0.11%
+25.6%
Q4 2019$2,111,000
-32.2%
557,027
-8.5%
0.09%
-37.7%
Q3 2019$3,115,000
-18.5%
609,019
-1.2%
0.14%
-9.2%
Q2 2019$3,823,000
-4.9%
616,664
+9.1%
0.15%
-5.6%
Q1 2019$4,019,000
-16.8%
565,3190.0%0.16%
-28.8%
Q4 2018$4,828,000
-61.5%
565,319
-9.8%
0.23%
-46.7%
Q3 2018$12,547,000
-11.7%
626,741
+13.9%
0.42%
-17.7%
Q2 2018$14,216,000
+11.7%
550,354
+3.4%
0.52%
+3.2%
Q1 2018$12,726,000
-29.1%
532,477
+0.5%
0.50%
-30.1%
Q4 2017$17,960,000
+60.1%
529,9370.0%0.71%
+52.6%
Q3 2017$11,219,000
+12.2%
529,937
-7.3%
0.47%
+7.3%
Q2 2017$10,001,000
-0.0%
571,7890.0%0.44%
-4.8%
Q1 2017$10,006,000
+3.5%
571,7890.0%0.46%
-0.4%
Q4 2016$9,663,000
+3.0%
571,7890.0%0.46%
-3.8%
Q3 2016$9,383,000
+10.7%
571,789
+2.1%
0.48%
+0.4%
Q2 2016$8,477,000
+8.8%
559,879
+4.0%
0.48%
+8.7%
Q1 2016$7,788,000
-39.1%
538,578
+19.2%
0.44%
-35.1%
Q4 2015$12,792,000
+110.9%
451,683
+24.7%
0.68%
+70.0%
Q3 2015$6,065,000
-27.0%
362,312
+14.4%
0.40%
-38.2%
Q2 2015$8,304,000
+45.1%
316,690
-3.0%
0.64%
+36.9%
Q1 2015$5,721,000
+55.5%
326,530
+54.1%
0.47%
+47.0%
Q4 2014$3,680,000
+14.1%
211,874
+22.3%
0.32%
+3.2%
Q3 2014$3,225,000
+66.1%
173,220
+63.1%
0.31%
+72.6%
Q2 2014$1,942,000106,2210.18%
Other shareholders

There were no reported owners of ADAMAS PHARMACEUTICALS INC in Q4 2016.

NameSharesValueWeighting ↓
View complete list of ADAMAS PHARMACEUTICALS INC shareholders